about
Longitudinal perspective on the conundrum of central arterial stiffness, blood pressure, and aging.Serum free thyroxine levels are positively associated with arterial stiffness in the SardiNIA study.Metabolic syndrome across Europe: different clusters of risk factors.No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque.Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference projectThe burden of obesity on blood pressure is reduced in older persons: the SardiNIA study.Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging.Gender specific profiles of white coat and masked hypertension impacts on arterial structure and function in the SardiNIA study.Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications.Can antihypertensive medication interfere with the vicious cycle between hypertension and vascular calcification?Pulse wave velocity as a marker of cognitive impairment in the elderly.Depression treatment selectively modifies arterial stiffness in older participants.Aortic stiffness and hypotension episodes are associated with impaired cognitive function in older subjects with subjective complaints of memory loss.How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension.Brain injury as end-organ damage in hypertension.Preventive geriatrics the cross-talk between arterial and brain aging: A lifelong condition.Depression is associated with increased occurrence of left ventricle concentric geometry in older subjects independently of blood pressure levels.Frequency of early vascular aging and associated risk factors among an adult population in Latin America: the OPTIMO study.Circadian blood pressure patterns and blood pressure control in patients with chronic kidney disease.Are Hemodynamic Factors Involved in Cognitive Impairment?Depression, hypertension, and comorbidity: disentangling their specific effect on disability and cognitive impairment in older subjects.Life-Course Approach to Chronic Disease: The Active and Healthy Aging Perspective.Characteristics of healthy vascular ageing in pooled population-based cohort studies: the global Metabolic syndrome and Artery REsearch Consortium.Pulse wave velocity distribution in a cohort studyHigh Prevalence of Poor Quality Drug Prescribing in Older Individuals: A Nationwide Report From the Italian Medicines Agency (AIFA)Decreased nocturnal systolic blood pressure fall in older subjects with depressionAn operational definition of SHATS (Systemic Hemodynamic Atherosclerotic Syndrome): Role of arterial stiffness and blood pressure variability in elderly hypertensive subjectsAnalgesic drug use in elderly persons: A population-based study in Southern ItalyThe appropriateness of antiplatelet and anticoagulant drug prescriptions in hospitalized patients in an internal medicine wardTo help aging populations, classify organismal senescenceThe hidden treasure of 24-hours ambulatory blood pressure monitoring-Assessing BP variabilityLancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressureCommon Carotid Artery Calcification Impacts on Cognitive Function in Older PatientsSystemic hemodynamic atherothrombotic syndrome (SHATS) - Coupling vascular disease and blood pressure variability: Proposed concept from pulse of AsiaArterial stiffness and multiple organ damage: a longitudinal study in populationMineralocorticoid Receptors in Metabolic Syndrome: From Physiology to Disease
P50
Q34506130-FEB7509A-BE72-4F8A-99A5-3BD3AD4962D1Q34765829-49D9D72C-50CF-4C66-BF97-72079A229015Q35982357-38A76D7F-F3DA-4924-B33E-4701933BF56FQ36385039-D0797F38-BA8A-4D5B-BB09-51A40E5DF077Q36686906-83E079AF-2F0B-447C-88E3-59BBD825D018Q36698250-AD38A0AA-E3E1-4CDC-96D9-ACC2E03BBC95Q37433637-847D3961-9C22-46B7-BDF4-C609B7AC7D52Q37550937-2F106FF0-32A8-4369-B96A-4FFAFB2F2C38Q37876175-8B5DFCE9-1A2E-4513-AC48-F9ED938C6D9EQ38148988-CF1F3E12-40D9-453D-9B49-F095ACA86173Q38245627-103A703B-02D0-413C-951F-4AC1A27AC619Q46444435-30B444CC-724D-411B-9A90-E882AFD2BD1BQ46873328-D3535E7F-A520-4B5E-8001-7CDC01CABB91Q48190874-AF4D97A7-77E8-4D06-9D19-E46D01BA38BEQ48309828-7252D3A0-DE56-45F7-A38E-A293005E2188Q48672339-676FF383-7882-4CAA-B61E-D0A14F20345EQ49104318-5067BC9C-2589-4761-BB0A-E549021E6989Q49789604-BF8A971D-2626-4DB2-B61C-8A439874F7C8Q50057319-4F80254A-244F-4E15-8FFA-6E67AAE5B718Q50549319-C69471B0-4738-452B-BC52-8722E2EC68F1Q51852403-FB3B09AB-AFD2-49D1-93D4-D2B1D3BBE429Q54351099-A973E3EA-7E89-4796-9B2B-4536AAE898D9Q57418608-49625E74-A5B1-4F81-A04C-1F5EB9728723Q57966428-EA129E9A-C7DA-4F40-84BD-43581389F8D9Q58946247-0A9473A3-31D9-4715-AF3E-F916FD8F6307Q84977408-A546029B-7273-4CB4-A1D7-654C96D7AF46Q88653579-7A454B35-19AE-407D-A5CF-B7781AF465D5Q90178968-26E7BF5E-DE6D-43A8-9FB3-A488FE24D761Q91019558-CFA4247B-3BCE-4E36-87D6-5B91876AE824Q91044240-1C5687D6-E99A-4C70-B677-1867D3F31D21Q91458220-FEA0D816-EDBE-48AA-A480-C0DA65A57C6EQ91603633-999B6DA0-B9AB-494B-87A8-596109B9CBEBQ91697288-7846F559-632A-4CE7-8571-4CC3436DB274Q91763901-A2FE8CE4-A022-464F-B885-206DCEB87DB3Q91858662-93F7EA0D-4F8D-4396-8AE3-A1E5B4C5F7CBQ92020668-B598F83B-53BD-4E31-A4FA-EBDD3338C10A
P50
description
researcher (ORCID 0000-0003-4784-5441)
@en
wetenschapper
@nl
name
Angelo Scuteri
@en
Angelo Scuteri
@nl
type
label
Angelo Scuteri
@en
Angelo Scuteri
@nl
prefLabel
Angelo Scuteri
@en
Angelo Scuteri
@nl
P31
P496
0000-0003-4784-5441